Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Beyond the 2024 McDonald criteria for defining and diagnosing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: March 03, 2026
Timothy K. Vartanian (1959-2025) pioneering neuroscientist who traced multiple sclerosis to a microbial source.
Journal: Multiple sclerosis and related disorders
Published: November 25, 2025
A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability Worsening.
Journal: Neurology
Published: April 23, 2025
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Journal: Neurology
Published: April 22, 2024
Magnetic resonance fingerprinting in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 06, 2023
Associations of sNfL with clinico-radiological measures in a large MS population.
Journal: Annals of clinical and translational neurology
Published: September 19, 2022
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 09, 2022
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
Journal: The Journal of clinical investigation
Published: July 13, 2022
Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform.
Journal: Frontiers in neurology
Published: May 03, 2022
Benefits of early treatment with natalizumab: a real-world study.
Journal: Multiple sclerosis and related disorders
Published: February 17, 2022
Measuring treatment response to advance precision medicine for multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: April 23, 2021
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: February 18, 2021
Last Updated: 09/26/2026